Position in CCCC
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$16,450,747
+$8,661,316 QoQ
Shares Held
3,522,644
+18.9% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#11
of 147 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names. CCCC ranks #2 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
|
368,568 | $23,197,669 | |
| 2 | CCCC |
C4 Therapeutics, Inc.
This page
|
3,522,644 | $16,450,747 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,307,247 | $14,183,629 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
312,767 | $12,201,040 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
443,668 | $9,853,866 | |
| 6 | MGNX |
Macrogenics Inc
|
2,018,881 | $9,327,230 | |
| 7 | IMTX |
Immatics N.V.
|
441,510 | $4,472,496 | |
| 8 | NKTX |
Nkarta, Inc.
|
1,577,847 | $4,465,307 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,450,747 | 3,522,644 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $7,789,431 | 2,961,761 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,298,793 | 4,344,918 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,773,085 | 4,852,741 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,617,266 | 7,424,662 | Shares | Sole | 2025-08-14 | |
| 2025-04-30 | $12,256,264 | 7,473,332 | Shares | Sole | 2025-05-07 | |
| 2025-03-31 | $10,759,054 | 6,724,409 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,861,363 | 6,072,601 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $32,360,997 | 5,677,368 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,393,833 | 4,847,150 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $35,363,673 | 4,328,479 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $40,335,061 | 7,138,949 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,619,682 | 6,247,141 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,798,600 | 7,199,491 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $17,948,305 | 5,716,021 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,076,617 | 5,775,698 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $52,045,354 | 5,934,476 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $42,726,601 | 5,666,658 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $37,324,616 | 1,538,525 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $41,713,876 | 1,295,462 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $59,962,659 | 1,342,047 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $52,578,263 | 1,389,489 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $40,134,408 | 1,085,007 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||